Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc.verified

XBIO

Price:

$3.2

Market Cap:

$6.04M

Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T cell (CAR T) platform is specifically engineered to identify and attack distinct tumor neoantigens found in individual patients. Beyond this specialized area, the company actively engages in the discovery, investigation, and creation of advanced biologic medicines and cancer treatments. A significant part of its cell-based therapeutic endeavors involves therapies designed to target the B-cell receptor on the exterior of malignant tumor cells in specific patients, with the aim of addressing B-cell lymphomas. Furthermore...[Read more]

Industry

Biotechnology

IPO Date

2016-06-30

Stock Exchange

NASDAQ

Ticker

XBIO

The Enterprise Value as of June 2026 (TTM) for Xenetic Biosciences, Inc. (XBIO) is -1303306.00

According to Xenetic Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1303306.00. This represents a change of 144.38% compared to the average of -533302.27 of the last 4 quarters.

Xenetic Biosciences, Inc. (XBIO) Historical Enterprise Value (quarterly & annually)

How has XBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Xenetic Biosciences, Inc. over the last ten years is 2.67M. The current -1303306.00 Enterprise Value has changed -4977.34% with respect to the historical average. Over the past ten years (40 quarters), XBIO's Enterprise Value was at its highest in in the December 2016 quarter at 362.26M. The Enterprise Value was at its lowest in in the December 2022 quarter at -8774786.85.

Quarterly (TTM)
Annual

Average

2.67M

Median

-1863173.44

Minimum

-9043302.45

Maximum

27.90M

Xenetic Biosciences, Inc. (XBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xenetic Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 26.72%

Maximum Annual Enterprise Value = 27.90M

Minimum Annual Increase = -414.62%

Minimum Annual Enterprise Value = -9043302.45

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-4191222.9326.72%
2024-15625.39-99.58%
2023-3710721.50-58.97%
2022-9043302.4582.45%
2021-4956561.00-414.62%
20201.58M-125.25%
2019-6240335.60-143.62%
201814.30M28.91%
201711.10M-60.23%
201627.90M27.97%

Xenetic Biosciences, Inc. (XBIO) Average Enterprise Value

How has XBIO Enterprise Value performed in the past?

The current Enterprise Value of Xenetic Biosciences, Inc. (XBIO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-2639189.94

5-year avg

-4383486.65

10-year avg

2.67M

Xenetic Biosciences, Inc. (XBIO) Enterprise Value vs. Peers

How is XBIO’s Enterprise Value compared to its peers?

Xenetic Biosciences, Inc.’s Enterprise Value is greater than Titan Pharmaceuticals, Inc. (-66329351.00), less than Ensysce Biosciences, Inc. (1.83M), less than Soligenix, Inc. (-1266892.00), greater than Oragenics, Inc. (-3242702.00), less than Qualigen Therapeutics, Inc. (971.81K), greater than Clearmind Medicine Inc. (-5840593.00), greater than Kazia Therapeutics Limited (-36657380.30), less than KALA BIO, Inc. (55.91M), less than Can-Fite BioPharma Ltd. (7.43B), greater than Abpro Corporation (-4541200.00),

Build a custom stock screener for Xenetic Biosciences, Inc. (XBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenetic Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xenetic Biosciences, Inc. (XBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xenetic Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Xenetic Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Xenetic Biosciences, Inc. (XBIO)?

What is the 3-year average Enterprise Value for Xenetic Biosciences, Inc. (XBIO)?

What is the 5-year average Enterprise Value for Xenetic Biosciences, Inc. (XBIO)?

How does the current Enterprise Value for Xenetic Biosciences, Inc. (XBIO) compare to its historical average?